We are live on ! Find out more
MGRX icon

Mangoceuticals
MGRX

6 hedge funds and large institutions have $148K invested in Mangoceuticals in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more capital invested

Capital invested by funds: $72K → $148K (+$75.7K)

0.52% more ownership

Funds ownership: 1.43% → 1.95% (+0.52%)

25% less funds holding

Funds holding: 8 → 6 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$30.5K
2
PI
PEAK6 Investments
Illinois
+$27.3K
3
UBS Group
UBS Group
Switzerland
+$11.9K
4
Citadel Advisors
Citadel Advisors
Florida
+$5.8K

Top Sellers

Rank Fund Capital Flow
1
MCG
McCollum Christoferson Group
New York
-$9.26K
2
XT
XTX Topco
Cayman Islands
-$5.36K
3
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$4.77K
4
BL
BFSG LLC
California
-$44

MGRX Hedge Fund Activity: Q2 2024 in Review

6 of the 6,938 institutional investors tracked by Wall St. Rank reported a position in Mangoceuticals (MGRX) for Q2 2024, worth a combined $148K — up 105% from $72K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MGRX and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $30.5K. The largest seller was McCollum Christoferson Group, exiting entirely with an estimated $9.26K sold.

  • 6 institutional investors held Mangoceuticals (MGRX) as of Q2 2024, down from 8 in Q1 2024.
  • Funds reported $148K of Mangoceuticals stock for Q2 2024, up 105% quarter-over-quarter.
  • 2 funds opened new Mangoceuticals positions in Q2 2024 and 4 closed out, a net change of -2 holders.
  • The largest Mangoceuticals buyer in Q2 2024 was Virtu Financial, an estimated $30.5K added.
  • The largest Mangoceuticals seller in Q2 2024 was McCollum Christoferson Group, an estimated $9.26K sold.

Based on aggregated 13F filings for Q2 2024.